Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

128 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
MDM4 is a rational target for treating breast cancers with mutant p53.
Miranda PJ, Buckley D, Raghu D, Pang JB, Takano EA, Vijayakumaran R, Teunisse AF, Posner A, Procter T, Herold MJ, Gamell C, Marine JC, Fox SB, Jochemsen A, Haupt S, Haupt Y. Miranda PJ, et al. Among authors: haupt s, haupt y. J Pathol. 2017 Apr;241(5):661-670. doi: 10.1002/path.4877. Epub 2017 Mar 1. J Pathol. 2017. PMID: 28097652
C-Abl as a modulator of p53.
Levav-Cohen Y, Goldberg Z, Zuckerman V, Grossman T, Haupt S, Haupt Y. Levav-Cohen Y, et al. Among authors: haupt s, haupt y. Biochem Biophys Res Commun. 2005 Jun 10;331(3):737-49. doi: 10.1016/j.bbrc.2005.03.152. Biochem Biophys Res Commun. 2005. PMID: 15865930 Review.
Mdm2 in growth signaling and cancer.
Levav-Cohen Y, Haupt S, Haupt Y. Levav-Cohen Y, et al. Among authors: haupt s, haupt y. Growth Factors. 2005 Sep;23(3):183-92. doi: 10.1080/08977190500196218. Growth Factors. 2005. PMID: 16243710 Review.
Importance of p53 for cancer onset and therapy.
Haupt S, Haupt Y. Haupt S, et al. Among authors: haupt y. Anticancer Drugs. 2006 Aug;17(7):725-32. doi: 10.1097/01.cad.0000217422.52208.fa. Anticancer Drugs. 2006. PMID: 16926623 Review.
PML enhances the regulation of p53 by CK1 in response to DNA damage.
Alsheich-Bartok O, Haupt S, Alkalay-Snir I, Saito S, Appella E, Haupt Y. Alsheich-Bartok O, et al. Among authors: haupt s, haupt y. Oncogene. 2008 Jun 12;27(26):3653-61. doi: 10.1038/sj.onc.1211036. Epub 2008 Feb 4. Oncogene. 2008. PMID: 18246126
p53 controls hPar1 function and expression.
Salah Z, Haupt S, Maoz M, Baraz L, Rotter V, Peretz T, Haupt Y, Bar-Shavit R. Salah Z, et al. Among authors: haupt s, haupt y. Oncogene. 2008 Nov 20;27(54):6866-74. doi: 10.1038/onc.2008.324. Epub 2008 Sep 29. Oncogene. 2008. PMID: 18820708
c-Abl phosphorylates Hdmx and regulates its interaction with p53.
Zuckerman V, Lenos K, Popowicz GM, Silberman I, Grossman T, Marine JC, Holak TA, Jochemsen AG, Haupt Y. Zuckerman V, et al. Among authors: haupt y. J Biol Chem. 2009 Feb 6;284(6):4031-9. doi: 10.1074/jbc.M809211200. Epub 2008 Dec 15. J Biol Chem. 2009. PMID: 19075013 Free article.
128 results